4.4 Gram-Positive Bacteria

Characteristics and Diversity of Gram-Positive Bacteria

Gram-positive bacteria share a defining feature: a thick peptidoglycan cell wall that retains crystal violet dye during Gram staining, making them appear purple under the microscope. Beyond that shared trait, they're split into two major groups based on DNA composition: high G+C bacteria (Actinobacteria) and low G+C bacteria (Firmicutes). The distinction matters because G+C content correlates with differences in cell wall architecture, metabolism, and the kinds of diseases (or benefits) each group produces.

G+C Content and What It Means

The "G+C content" refers to the percentage of guanine and cytosine nucleotides in an organism's DNA. Because G-C base pairs form three hydrogen bonds (compared to two for A-T pairs), higher G+C content means the DNA has a higher melting temperature and greater thermal stability.

High G+C: Actinobacteria (>50% G+C)

• Commonly found in soil, where they drive decomposition and nutrient cycling of carbon and nitrogen
• Possess thicker, more rigid cell walls with higher peptidoglycan content, giving them increased protection against environmental stressors like desiccation and UV radiation
• Some genera, especially Streptomyces, produce a huge range of clinically important antibiotics, including streptomycin and tetracycline. Over two-thirds of naturally derived antibiotics come from Actinobacteria.

Low G+C: Firmicutes (<50% G+C)

• Have thinner cell walls with less peptidoglycan compared to Actinobacteria
• Include many clinically significant pathogens: Staphylococcus aureus, Streptococcus pyogenes, and Clostridioides difficile
• Also include beneficial species used in food production, such as Lactobacillus (yogurt, cheese) and Bacillus (probiotics, industrial enzymes)

Actinobacteria vs. Firmicutes Comparison

Structural differences:

1. Actinobacteria have a more complex cell wall architecture, sometimes featuring additional layers like mycolic acids that contribute to environmental resilience.
2. Firmicutes have a simpler wall structure, primarily peptidoglycan without those extra layers.
3. Certain Actinobacteria genera (Mycobacterium) produce a waxy mycolic acid outer layer that makes them acid-fast, meaning they resist standard Gram staining and require the Ziehl-Neelsen acid-fast stain instead. Firmicutes are not acid-fast.

Metabolic differences:

1. Actinobacteria are predominantly aerobic with a diverse metabolic repertoire, enabling them to break down tough organic compounds like lignin and chitin.
2. Firmicutes include both aerobic and anaerobic species. Some perform fermentation (Lactobacillus), and certain genera (Bacillus, Clostridium) can form endospores, dormant structures that survive extreme conditions.
3. Actinobacteria are best known for producing secondary metabolites like antibiotics, while Firmicutes more commonly produce toxins (enterotoxins, neurotoxins).

Cell Wall Structure and Gram Staining

All Gram-positive bacteria share a thick peptidoglycan layer, which can be up to 40 layers deep. Embedded within this layer are teichoic acids, polymers unique to Gram-positive bacteria that help maintain cell wall rigidity, regulate ion movement, and play a role in cell division.

The Gram staining procedure, developed by Hans Christian Gram in 1884, exploits this thick peptidoglycan layer:

1. Apply crystal violet (primary stain) to a heat-fixed smear.
2. Add Gram's iodine (mordant), which forms a crystal violet-iodine complex trapped within the cell wall.
3. Decolorize with alcohol or acetone. Gram-positive bacteria retain the dye because their thick peptidoglycan prevents the complex from washing out.
4. Counterstain with safranin. Gram-positive cells still appear purple because the crystal violet masks the pink safranin.

The result: Gram-positive bacteria look purple, while Gram-negative bacteria (with thinner peptidoglycan) lose the crystal violet and pick up the pink safranin counterstain.

Clinical Relevance of Gram-Positive Bacteria

Several Gram-positive species are among the most important human pathogens. Knowing which organism causes which disease, and why each is difficult to treat, comes up repeatedly in microbiology.

Staphylococcus aureus (Firmicutes)

• Causes infections ranging from mild skin infections (boils, impetigo) to life-threatening conditions like pneumonia, endocarditis, and sepsis
• MRSA (methicillin-resistant S. aureus) carries the mecA gene, which encodes an altered penicillin-binding protein (PBP2a) that beta-lactam antibiotics can't target. MRSA is a major concern in both hospitals and the community.

Streptococcus pyogenes (Firmicutes)

• Causes strep throat, scarlet fever, and necrotizing fasciitis ("flesh-eating disease")
• Can trigger post-infectious complications weeks after the initial infection: rheumatic fever (which damages heart valves) and glomerulonephritis (which damages kidney filtration). These are immune-mediated, not direct bacterial damage.

Clostridioides difficile (Firmicutes)

• The leading cause of antibiotic-associated diarrhea and pseudomembranous colitis, typically occurring after broad-spectrum antibiotic use disrupts normal gut flora
• Difficult to eliminate because it forms endospores that persist on surfaces and resist standard disinfection. Recurrent infections are common.

Mycobacterium tuberculosis (Actinobacteria)

• Causes tuberculosis (TB), a chronic respiratory infection that can also disseminate to bones, brain, and kidneys
• Its waxy mycolic acid cell wall makes it naturally resistant to many antibiotics and contributes to its slow growth rate. Treatment requires a prolonged multi-drug regimen (typically 6-9 months with drugs like isoniazid, rifampin, ethambutol, and pyrazinamide). MDR-TB and XDR-TB (multidrug- and extensively drug-resistant strains) are growing global threats.

Bacillus anthracis (Firmicutes)

• Causes anthrax, a rare but potentially fatal zoonotic disease with three main forms: cutaneous (skin), gastrointestinal, and inhalational (the most lethal)
• B. anthracis endospores are extremely stable in the environment and have been weaponized as a biological agent. Inhalational anthrax has a very high mortality rate if not treated early with antibiotics like ciprofloxacin or doxycycline.